Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist illustration of a muscle fiber silhouette in a dark palette.

Oct 28, 2026

Anthropic acquires Mithril, a one-man biotech run with Claude

Anthropic has made headlines by acquiring Mithril Medicine, a one-man biotech company led by Cody Tranbarger, who is also known for his pseudonymous insights on pharmaceutical research.The acquisition is part of Anthropic's strategy to accelerate its drug development efforts, particularly targeting rare forms of muscular dystrophy. Mithril operates uniquely, with Tranbarger leveraging AI, specifically Claude, to manage various tasks including contracts, logistics, and experiment tracking across
A minimalist representation of a pharmaceutical package in flat design.

Oct 28, 2026

PAXAFE’s Mark Talens Sees AI Agents Ending the Dashboard Era

Mark Talens from PAXAFE predicts a shift away from traditional dashboards in pharmaceutical supply chain management, emphasizing the role of AI agents in enhancing operational efficiency.During his presentation at LogiPharma USA 2026, Talens highlighted the evolution of supply chain visibility, noting that pharmaceutical companies can now analyze their entire value chain across various functions simultaneously. He remarked on the rapid advancements in decision intelligence, particularly through
A surgical instrument on a sterile table in a dimly lit surgical room.

Oct 28, 2026

How AI is generating new possibilities across MedTech industry

The integration of artificial intelligence (AI) in the medical device sector is reshaping expectations around product development, emphasizing not just speed but also the reliability of results.During a recent webinar featuring experts from Critical Software, IQ Inc., and Bausch + Lomb, the discussion highlighted the evolving demands from clients. Today, stakeholders seek transparency regarding AI's application in software development, focusing on how AI tools are utilized and the verification o
A minimalist gear icon representing validation processes in pharmaceuticals.

Oct 28, 2026

Crossing the Digital Validation Chasm

Researchers from the University of Limerick highlight a significant gap in digital validation processes within the pharmaceutical manufacturing sector, proposing a risk-based workflow to bridge this divide.The study points out that the disconnect between traditional validation methods and advanced digital strategies is not primarily a regulatory issue. Instead, it stems from the challenge of effectively integrating risk-based validation principles into everyday engineering practices. Dermot McMo
A petri dish containing a soil sample, showcasing microbial life in a laboratory setting.

Oct 28, 2026

Microbial Dark Matter Could Revive Antibiotics

Recent research emphasizes the untapped potential of "microbial dark matter" in the quest for new antibiotics, highlighting the limitations of traditional discovery methods.According to a review by researchers Ahmed Hamed and Zeinab Khalil from the University of Queensland, the search for novel antibiotics has largely focused on familiar microorganisms, often leading to the rediscovery of known compounds. This approach has proven inadequate, particularly as antimicrobial resistance accounts for
A clipboard with medical paperwork in a dimly lit hospital office

Oct 28, 2026

How Inspira Health managed the people behind its switch to Epic

The transition of Inspira Health to the Epic electronic health record system exemplifies the complexity of such an undertaking, highlighting the importance of human factors in technology migrations.Over a 19-month period, Inspira Health underwent a significant migration from Oracle Millenium to Epic, engaging approximately 9,000 end-users across 383 departments. This transition was framed not merely as a technological upgrade but as an organizational transformation. David Mills, director of the
Press release cover image

Oct 28, 2026

Press release

Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator Licenses SpeechDx Dataset to Eli Lilly and Company, Advancing Speech-Based Markers as a Critical Alzheimer's Research Tool

Lilly's partnership signals growing industry recognition of AI-driven speech analysis as a path to predicting Alzheimer's disease riskNEW YORK, Oct. 28, 2026 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostics Accelerator (DxA) announces a new collaboration with Eli Lilly and Company, which has licensed the ADDF's SpeechDx dataset, the world's largest harmonized longitudinal dataset of speech and biomarker data spanning the Alzheimer's continuum, from cognitively unimp
Press release cover image

Oct 28, 2026

Press release

Suvoda helps patients stay in trials with more travel choice and control through expanded Greenphire Travel

Key TakeawaysRideshare access expanded for clinical trial participants—Lyft, Uber Health, and Bolt provide direct access to ground transportation and cut routine coordination work for sites.One app now covers the entire trial journey—participants can view travel itineraries, book eligible rides, and manage study appointments and payments through the Suvoda App.Travel support flexes to match trial complexity—sites can directly initiate routine travel requests or choose a fully managed Concierge m
Nurse reviewing medical chart with patient in Kenyan healthcare facility.

Oct 28, 2026

Digital health in Kenya: How AI is reshaping nursing care

In Kenya's pursuit of Universal Health Coverage (UHC), the integration of digital health and artificial intelligence (AI) is significantly transforming nursing care and healthcare delivery.The ongoing shift towards digital systems in Kenya is aimed at enhancing patient safety, clinical decision-making, and access to healthcare. By mid-2026, a reported 5,078 healthcare facilities are expected to utilize the Health Management Information System, which streamlines access to patient histories and im
Press release cover image

Oct 28, 2026

Press release

Herzing University Adds Five New, Redesigned and Expanded Healthcare Programs to Meet Workforce Demand

Programs in nursing, health information, surgical technology and behavioral health reflect how technology and AI are reshaping careMILWAUKEE, Oct. 28, 2026 /PRNewswire/ -- Herzing University, an accredited, private nonprofit institution, today announced five program launches, redesigns and expansions this fall, spanning nursing, health information, surgical technology and behavioral health. The additions include new graduate options, updated curricula that reflect how technology and AI are resha
Press release cover image

Oct 28, 2026

Press release

Harvard Pilgrim Adds Well-Being Solutions to its Suite of Products

New and expanded relationships with key clinical partners will assist members to live healthier livesCANTON, Mass., Oct. 28, 2026 /PRNewswire/ -- Harvard Pilgrim Health Care, a Point32Health company, today announced new partnerships, as well as expanded relationships with clinical and well-being companies, aimed at simplifying care, while assisting members in their health care journeys."Employers and consumers are looking for health care solutions that are easier to understand, more affordable a
Press release cover image

Oct 28, 2026

Press release

Formation Bio Announces $600 Million Debut Fund to Expand Drug Development Capacity

Formation Bio Drug Development Accelerator Fund pairs dedicated capital with the company's AI-native development platform to scale its portfolio of clinical-stage medicinesNEW YORK, Oct. 28, 2026 /PRNewswire/ -- Formation Bio, an AI-native pharmaceutical company, today announced the Formation Bio Drug Development Accelerator Fund (the "Fund"), with $600 million in capital commitments. The Fund is designed to expand the company's portfolio of clinical-stage medicines. Combining dedicated capital